Zum Hauptinhalt springen

Impact of the period of the day on all-cause mortality and major cardiovascular complications after arterial vascular surgeries.

Artioli, T ; Gualandro, DM ; et al.
In: PloS one, Jg. 18 (2023-01-05), Heft 1, S. e0279873
Online academicJournal

Impact of the period of the day on all-cause mortality and major cardiovascular complications after arterial vascular surgeries  Introduction

Background: Conflicting results are reported about daytime variation on mortality and cardiac outcomes after non-cardiac surgeries. In this cohort study, we evaluate whether the period of the day in which surgeries are performed may influence all-cause mortality and cardiovascular outcomes in patients undergoing non-cardiac arterial vascular procedures. Methods: 1,267 patients who underwent non-cardiac arterial vascular surgeries between 2012 and 2018 were prospectively included in our cohort and categorized into two groups: morning (7 a.m. to 12 a.m., 79%) and afternoon/night (12:01 p.m. to 6:59 a.m. in the next day, 21%) surgeries. Primary endpoint was all-cause mortality within 30 days and one year. Secondary endpoints were the incidence of perioperative myocardial injury/infarction (PMI), and the incidence of major adverse cardiac events (MACE, including acute myocardial infarction, acute heart failure, arrhythmias, cardiovascular death) at hospital discharge. Results: After adjusting for confounders in the multivariable Cox proportional regression, all-cause mortality rates at 30 days and one year were higher among those who underwent surgery in the afternoon/night (aHR 1.6 [95%CI 1.1–2.3], P = 0.015 and aHR 1.7 [95%CI 1.3–2.2], P < 0.001, respectively). Afternoon/night patients had higher incidence of PMI (aHR 1.4 [95%CI 1.1–1.7], P < 0.001). There was no significant difference in the incidence of MACE (aHR 1.3 [95%CI 0.9–1.7], P = 0.074). Conclusions: In patients undergoing arterial vascular surgery, being operated in the afternoon/night was independently associated with increased all-cause mortality rates and incidence of perioperative myocardial injury/infarction.

Cardiovascular disease is a major postoperative cause of morbidity and mortality in patients submitted to arterial vascular surgery.1 The high prevalence of atherosclerosis and the coexistence of several cardiovascular risk factors increase mortality and postoperative cardiac complications [[1]].

In the perioperative period, acute myocardial infarction (AMI), acute heart failure, cardiac arrhythmias and perioperative myocardial injury/infarction (PMI) are associated with increased length of hospital stay, elevated costs and increased mortality [[3]]. PMI was recently described as an important complication after non-cardiac surgeries, being independently associated with high mortality rates in short and long follow-up [[5]–[8]]. Developing strategies to reduce the occurrence of perioperative cardiac complications and to better understand PMI is essential to improve outcomes for this group of high risk patients.

Overall, cardiovascular events can be influenced by the circadian cycle, with higher rates and worse outcomes of events occurring in the early morning [[9]–[13]]. However, there is still a gap in the literature assessing daytime variation of cardiovascular outcomes in the perioperative period. The variations on blood pressure, heart rate, hormone levels and many other pathophysiological mechanisms might affect perioperative outcomes [[14]]. A recent pilot study including patients submitted to aortic valve replacement assessed whether this time pattern occur after cardiac surgeries, showing that the incidence of major cardiovascular complications in patients undergoing surgery in the afternoon is lower [[15]]. Likewise, a cohort study conducted to assess daytime variation in cardiovascular events after non-cardiac surgeries did not find an influence of the time of the surgery on PMI, but the incidence of acute myocardial infarction was higher in the afternoon group [[16]].

On the other hand, several studies have shown worse outcomes in surgeries performed at weekends or holidays even after correcting for surgeon experience. The smaller levels of staff, consulting services and diagnostics exams available at night or weekends might result in more surgery complications [[17]].

In non-cardiac arterial vascular surgeries, there is no conclusive data about the association of cardiovascular complications and the period of the day in operating room. Our goal is to evaluate whether the period of the day in which surgeries are performed may influence all-cause mortality and major cardiac complications in patients undergoing non-cardiac arterial vascular interventions.

Materials and methods

Study overview and population

This is part of a prospective cohort registry including consecutive patients undergoing non-cardiac arterial vascular surgery between 2012 and 2018 at Hospital das Clínicas, University of São Paulo Medical School, São Paulo, Brazil, for whom a preoperative cardiologic consultation was requested. Cardiology consultation and perioperative evaluation is provided in less than 24 hours in our hospital. For this study, we excluded patients from whom it was not possible to perform perioperative cardiovascular evaluation or to obtain time of the surgery with the available documentation. We included patients undergoing all arterial vascular surgeries: open or endovascular (for aorta, peripheral artery, visceral artery, and carotid artery diseases and amputations due to limb ischemia), emergent, urgent, or elective. Of note, in the present study, urgent/emergency procedures were considered interventions for acute onset pathologies or clinical deterioration without previously schedule or outpatient evaluation that were able to receive perioperative cardiac evaluation.

Procedures

Baseline characteristics of the patients were obtained from the clinical and laboratorial records registered in the preoperative cardiologic consultation. Perioperative surveillance with high-sensitive cardiac Troponin T (hs-cTnT) was performed, according to current guidelines [[18]]. Perioperative surveillance included serial measurements of hs-cTnT (Roche Diagnostics, Indianapolis, Ind) once daily up to the second or third day after surgery and 12-lead electrocardiography daily. Additional electrocardiography and hs-cTnT measurements were performed whenever clinically indicated. The patient was included in the register just once in the index operations. Reoperations in the same hospitalization were not included.

Variables of interest from all screened patients are registered in a dedicated prospective database. Since the Revised Cardiac Risk Index already contains heart failure as one of its variables, chronic heart failure was not included in the multivariable analysis.

The exact time of surgery was obtained from the anesthetic record. In cases of impossibility to obtain the anesthetic record, the exact time of the surgery was obtained from the records of the nursing staff of the operating room (time of entry into the operating room).

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Study protocol was approved by the Local Research Ethics Committee of the Hospital das Clínicas, University of São Paulo Medical School, Brazil (approval number: 30217414.5.0000.00068). The need for Informed Consent was waived by the ethics committee.

We adhered to the STROBE guidelines for observational studies (S1 Table).

Definition of "morning" and "afternoon/night" surgeries

Before the analysis, we defined surgeries in the "morning" period as procedures for which the first incision occurred between 7 a.m. and 12 a.m.; and surgeries in the "afternoon/night" period as procedures for which the first incision occurred between 12:01 p.m. and 6:59 a.m. of the next day. These time intervals reflect the Hospital work shifts of the surgical at our study center and are an example of the pattern of categorization between morning and afternoon surgeries previously described in the literature [[15]].

Definition of study endpoints

Primary endpoint was all-cause mortality within 30 days and one year follow-up. 30-days follow-up was made by in-hospital stay registries, postoperative consultation data or telephone calls. One year follow-up for all-cause mortality was made by telephone calls, patient's charts and local death registries (with the appropriate death date confirmed).

Secondary endpoints included the incidence of perioperative myocardial injury/infarction (PMI) and the incidence of major adverse cardiac events (MACE). PMI and MACE were followed-up until hospital discharge by in-hospital stay registries.

PMI was defined as an absolute delta of hs-cTnT concentrations ≥ 14ng/L above the baseline concentrations within 3 days after the operation. In the absence of a preoperative hs-cTnT, PMI was defined as a delta ≥ 14ng/L between two postoperative concentrations [[6]].

MACE was a composite endpoint, including acute myocardial infarction, acute heart failure, new or decompensated arrhythmias requiring treatment, and cardiovascular death within 30 days after the surgery, which were defined according to the following criteria:

  • Acute myocardial infarction (AMI): defined according to the 4th universal definition of AMI [[18]]. AMI is diagnosed in the presence of elevation and decrease of myocardial necrosis markers (troponin) above reference value associated with at least one of the following criteria: I. Symptoms of myocardial ischemia; II. Electrocardiographic signs compatible with ischemia; III. New segmental change on the echocardiogram or evidence of myocardial injury in imaging studies; IV. Coronary angiography with acute coronary lesion. All AMI cases were adjudicated by two independent cardiologists.
  • Acute Heart Failure: diagnosed by cardiologist or attending physician, using clinical symptoms, physical examination findings, chest radiography, BNP or serum NT-proBNP and echocardiography, according to current guidelines [[20]].
  • Arrhythmias (atrial fibrillation/flutter, supraventricular tachycardia, ventricular tachycardia): diagnosed when considered clinically significant, i.e., drug therapy or electrical cardioversion.
  • Cardiovascular death: deaths were classified as cardiovascular or non-cardiovascular according to guidelines. Deaths were considered cardiovascular, unless evidence of a non-cardiovascular cause was documented [[22]].
Statistical analysis

Categorical variables were presented by numbers and percentages (frequencies) and were compared using Pearson's Chi-squared test with Yates' continuity. Continuous variables were presented as medians and interquartile ranges and were compared using the Mann-Whitney test (tabular results, unpaired), assuming non normal distribution.

All-cause mortality was described between patients operated in the morning vs in the afternoon/night in a descriptive analysis, with P-values calculated by Log-Rank test, and Hazard-Ratios (HR) with 95% Confidence Intervals (CI) calculated by Univariate Cox regression analysis. Both 30 days and one year follow-up were considered in the analysis.

PMI was described between patients operated in the morning vs in the afternoon/night in a descriptive analysis, with P-values calculated by Pearson's Chi-squared test with Yates' continuity (x2 test), and Odds-Ratio (OR) with 95% CI calculated by Baptista-Pike method. MACE were described between patients operated in the morning vs in the afternoon/night in a descriptive analysis, with P-values calculated by Log-Rank test, and Hazard-Ratios (HR) with 95% Confidence Intervals (CI) calculated by Univariate Cox regression analysis.

For the multivariable analysis, we calculated the adjusted Hazard-Ratios (aHR) and 95% CI using Multivariate Cox regression analysis to adjust for confounding variables. Our Regression Model and population was considered strong enough to estimate the effect size of each variable/confounder, allowing to identify the interaction effects between treatment and confounders. Significant clinical and laboratory variables in the univariable analysis were included in the multivariable model. Based on the number of events and the consensus of requiring 10 events for each independent variable, we could address all variables with a P < 0.05 in the univariable analysis. Loss of follow-up and missing data are indicated in the descriptive text before tables and figures. No imputation was performed for missing values.

The statistical significance level considered was 95% (P < 0.05). Statistical analyses were performed using the software R for Windows, R Core Team (2020—R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https://www.R-project.org/).

Sensitivity analysis

Sensitivity Analysis—Since urgent/emergency surgeries are more frequent in the night period they could be correlated variables. To avoid confounding results a sensitivity analysis was made considering only the population undergoing urgent/emergency surgery, submitting them to the same statistical analysis performed in the main cohort.

Results

Study cohort

Between 2012 and 2018, 1,296 patients went to preoperative cardiologic consultation before arterial vascular surgery (S1 Fig), of which 29 patients were excluded, leaving 1,267 for inclusion in our cohort (S2 Fig).

Baseline characteristics

Of the 1,267 patients, 1,002 (79.1%) underwent arterial vascular surgery in the morning and 265 (20.9%) in the afternoon/night period (Table 1). Urgent/emergency surgeries were more prevalent in the afternoon/night group. Male gender patients were more prevalent in both groups with a median age of 68 years. Patients in the afternoon/night group had more comorbidities such as diabetes mellitus requiring insulin, hypertension, chronic heart failure, had more preoperative use of clopidogrel, and less use of aspirin. Finally, the morning group had higher hemoglobin levels.

Graph

Table 1 Baseline characteristics of the 1,267 patients in the cohort.

All PatientsAfternoon surgeryMorning surgeryP-value
n = 1267n = 265n = 1002
n (%)n (%)n (%)
Male gender, n (%)881 (69.5%)176 (66.4%)705 (70.4%)0.244
Age (years), median (IQR)68 [61–75]68 [61.5–75]68 [61–75]0.937
Diabetes mellitus, n (%)
 No insulin, n (%)330 (26.0%)80 (30.2%)250 (25.0%)0.068
 Insulin, n (%)160 (12.6%)52 (19.6%)108 (10.8%)
Smoking, n (%)
 Smoker, n (%)265 (20.9%)54 (20.4%)211 (21.1%)0.587
 Former smoker, n (%)668 (52.7%)124 (46.8%)544 (54.3%)
Hypertension, n (%)1079 (85.2%)235 (88.7%)844 (84.2%)0.087
Coronary artery disease, n (%)482 (38.0%)103 (38.9%)379 (37.8%)0.810
COPD, n (%)78 (6.2%)17 (6.4%)61 (6.1%)0.957
Chronic heart failure, n (%)219 (17.3%)60 (22.6%)159 (15.9%)0.013
Stroke/transient ischemic attack, n (%)
 TIA, n (%)52 (4.1%)8 (3.0%)44 (4.4%)0.130
 Stroke, n (%)265 (20.9%)70 (26.4%)195 (19.5%)
Urgent/Emergency Surgery, n (%)478 (37.7%)181 (68.3%)297 (29.6%)< 0.001
Revised cardiac risk index
 I, n (%)94 (7.4%)32 (12.1%)62 (6.2%)0.006
 II, n (%)480 (37.9%)90 (34.0%)390 (38.9%)
 III, n (%)391 (30.9%)75 (28.3%)316 (31.5%)
 IV, n (%)302 (23.8%)68 (25.7%)234 (23.4%)
Preoperative Medications
 ASA, n (%)1014 (80.0%)200 (75.5%)814 (81.2%)0.093
 Clopidogrel, n (%)93 (7.3%)30 (11.3%)63 (6.3%)0.006
 Statins, n (%)1164 (91.9%)219 (82.6%)945 (94.3%)< 0.001
 ACEI, n (%)401 (31.6%)82 (30.9%)319 (31.8%)0.962
 Angiotensin receptor blockers, n (%)293 (23.1%)57 (21.5%)236 (23.6%)0.619
Betablockers, n (%)
 Started before surgery, n (%)50 (3.9%)7 (2.6%)43 (4.3%)0.392
 Chronic, n (%)576 (45.5%)111 (41.9%)465 (46.4%)
 Withdraw before surgery, n (%)26 (2.1%)7 (2.6%)19 (1.9%)
Laboratory assessment
 Creatinine (mg/dL), median [IQR]1.11 [0.88–1.42]1.08 [0.84–1.46]1.12 [0.89–1.41]0.403
 Hemoglobin (g/dL), median [IQR]12.80 [11.10–14.20]12.20 [9.93–13.80]13.00 [11.40–14.30]< 0.001

1 IQR: interquartile range; COPD: chronic obstructive pulmonary disease; TIA: transient ischemic attack; ASA: acetylsalicylic acid; ACEI: Angiotensin-converting enzyme inhibitors.

Primary endpoint: All-cause mortality

Of 1,267 patients included in the cohort, one year follow-up was complete in 91,9%. Overall, 152 (12.0%) patients died after 30 days and 260 (20.5%) after one-year (Table 2). Significant increase in all-cause mortality in the afternoon/night surgery group was observed after 30 days (HR 2.29 [95%CI 1.65–3.19], P-value < 0.001) and one year (HR 2.38 [95%CI 1.85–3.07], P-value < 0.001).

Graph

Table 2 All-cause mortality after 30 and one year of follow-up and MACE.

All PatientsAfternoon surgeryMorning surgeryHR (95%CI)P-value
n = 1267n = 265n = 1002
n (%)n (%)n (%)
All-cause mortality 30 days152 (12.0%)55 (20.8%)97 (9.7%)2.29 [1.65–3.19]< 0.001
MACE Hospital Discharge302 (23.8%)97 (36.6%)205 (20.5%)1.93 [1.52–2.46]< 0.001
 Cardiovascular Death73 (5.8%)20 (7.5%)53 (5.3%)1.42 [0.85–2.38]0.200
 Myocardial infarction147 (11.6%)48 (18.1%)99 (9.9%)1.87 [1.32–2.64]< 0.001
 Acute heart failure132 (10.4%)59 (22.3%)73 (7.3%)3.32 [2.35–4.68]< 0.001
 Arrhythmia72 (5.7%)24 (9.1%)48 (4.8%)1.94 [1.19–3.17]0.007
All PatientsAfternoon surgeryMorning surgeryHR (95%CI)P-value
n = 1164n = 238n = 926
n (%)n (%)n (%)
All-cause mortality one year260 (20.5%)92 (34.7%)168 (16.8%)2.38 [1.85–3.07]< 0.001

2 MACE: major adverse cardiac events; HR: hazard ratio.

After adjusting for confounding variables in the multivariable analysis, all-cause mortality at 30 days remained higher among those who underwent surgery in the afternoon/night period (aHR 1.6 [95%CI 1.1–2.3], P = 0.015; Table 3). The increased mortality persisted after one year in those that had surgery in the afternoon/night (aHR 1.7 [95%CI 1.3–2.2], P < 0.001; Table 3). Mortality curves are depicted in Fig 1.

Graph: Fig 1 All-cause mortality after arterial vascular surgery.Groups according to the start time of the procedure in the cohort population in 30 days (A) and one-year (B) follow-up.

Graph

Table 3 Multivariable analysis by Cox regression model—All-cause mortality.

Adjusted HRP-valueAdjusted HRP-value
(95%CI)(95%CI)
30 daysOne year
All-cause mortality
 Afternoon surgery1.58 (1.09–2.29)0.0151.68 (1.27–2.22)< 0.001
 Urgent/Emergency Surgery1.51 (1.02–2.23)0.0411.34 (0.99–1.81)0.055
 Revised Cardiac Risk Index I----
 Revised Cardiac Risk Index II1.54 (0.80–2.98)0.1961.22 (0.77–1.95)0.395
 Revised Cardiac Risk Index III1.72 (0.87–3.39)0.1181.28 (0.79–2.08)0.323
 Revised Cardiac Risk Index IV1.81 (0.92–3.58)0.0861.67 (1.04–2.70)0.035
 Clopidogrel0.59 (0.28–1.23)0.1570.84 (0.52–1.37)0.489
 Statins0.64 (0.39–1.05)0.0770.69 (0.46–1.03)0.071
 Hemoglobin (g/dL)0.85 (0.78–0.92)< 0.0010.81 (0.76–0.86)< 0.001

3 aHR: adjusted hazard ratio.

Patients with higher Revised Cardiac Risk Index classifications had higher incidence of all-cause mortality. On the other hand, higher hemoglobin levels were associated with decreased incidences of mortality in both 30 days and one year.

Secondary endpoints: PMI and MACE incidences

For this analysis, 88 (6.9%) patients did not have two consecutive values of hs-cTnT for the evaluation of PMI and were considered missing data. Overall, 351 (27.7%) patients had PMI after surgery. The incidence of PMI was higher in patients of the afternoon/night group than in patients of the morning group: 37.4% versus 25.1%, respectively (OR 1.77 [95%CI 1.34–2.36], P-value < 0.001).

In the multivariable analysis, surgeries that occurred in the afternoon/night group were also independently associated with higher PMI incidence (Table 4). Urgent/emergency surgeries were associated with higher PMI rates. Also, patients with higher Revised Cardiac Risk Index classifications had higher incidence of PMI. Preoperative clopidogrel was associated with lower incidence of PMI.

Graph

Table 4 Multivariable analysis by Cox regression model—PMI and MACE.

Adjusted HRP-value
(95%CI)
PMI
 Afternoon surgery1.35 (1.05–1.74)0.020
 Urgent/Emergency Surgery1.78 (1.39–2.28)< 0.001
 Revised Cardiac Risk Index I--
 Revised Cardiac Risk Index II2.23 (1.30–3.84)0.004
 Revised Cardiac Risk Index III2.68 (1.55–4.65)< 0.001
 Revised Cardiac Risk Index IV3.14 (1.81–5.44)< 0.001
 Clopidogrel0.35 (0.20–0.62)< 0.001
 Statins0.64 (0.44–0.93)0.021
 Hemoglobin (g/dL)0.93 (0.88–0.97)0.003
MACE
 Afternoon surgery1.27 (0.98–1.66)0.074
 Urgent/Emergency Surgery1.71 (1.30–2.26)< 0.001
 Revised Cardiac Risk Index I--
 Revised Cardiac Risk Index II1.39 (0.89–2.18)0.152
 Revised Cardiac Risk Index III1.45 (0.91–2.31)0.117
 Revised Cardiac Risk Index IV1.66 (1.04–2.65)0.034
 Clopidogrel0.73 (0.46–1.17)0.193
 Statins0.44 (0.31–0.61)< 0.001
 Hemoglobin (g/dL)0.85 (0.80–0.90)< 0.001

4 aHR: adjusted hazard ratio. PMI: perioperative myocardial injury/infarction. MACE: major adverse cardiac events.

At hospital discharge, the incidence MACE was higher in the afternoon/night surgery group (Table 2). Surgeries occurring in the afternoon/night period were not independently associated with increased MACE after correction for confounders (Table 4). However, urgent/emergency surgeries and higher Revised Cardiac Risk Index classifications were associated with elevated occurrence of MACE. The use of preoperative statins and higher hemoglobin levels were associated with lower rates of MACE.

Sensitivity analysis

Of the total, 478 patients underwent urgent/emergency surgery: 181 (37.9%) during the morning and 297 (62.1%) during the afternoon/night period. Considering only urgent/emergency surgery population, significant increase in all-cause mortality in the afternoon/evening surgery group was observed after 30 days (HR 2.57 [95% CI 1.69–3.93], P value < 0.001) and one year (HR 2.43 [95% CI 1.75–3.37], P value < 0.001). After multivariate analysis, 30-day all-cause mortality was higher in the afternoon/night period (aHR 2.43 [95%CI 1.54–3.83], P = < 0.001), as well as one year mortality (aHR 2.35 [95%CI 1.65–3.33], P = < 0.001)–(S3 Fig).

The incidence of PMI in the urgent/emergency surgery group was also higher in patients operated in the afternoon/evening period: 44.2% versus 33.0%, respectively (OR 1.82 [95%CI 1.22–2.71], P- value = 0.003). In the multivariate analysis, urgent/emergency surgeries performed in the afternoon/evening presented independent association with the incidence of PMI (aHR 1.4 [95%CI 1.03–1.91], P = 0.03). After 30 days, the incidence of MACE in urgent/emergency surgery group was higher in the afternoon/evening surgery population. Surgeries performed in the afternoon/evening period were independently associated with increased MACE after correction for confounding factors in the multivariable analysis (aHR 1.51 [95%CI 1.10–2.06], P = 0.010).

Discussion

In this prospective cohort study, we aimed to investigate whether the period of the day in which surgeries are performed may influence all-cause mortality, perioperative myocardial injury/infarction (PMI) and major adverse cardiac events (MACE) in patients undergoing non-cardiac arterial vascular procedures. We observed that surgeries performed in the afternoon/night period were associated with higher all-cause mortality at 30 days and one year and elevated PMI incidence (Fig 2). The incidence of MACE at hospital discharge, however, was not different between morning and afternoon/night surgical groups.

Graph: Fig 2 Graphical abstract.In patients submitted to arterial vascular surgery, being operated in the afternoon/night period was independently associated with increased mortality rates and higher incidence of PMI. O: outcomes. T: time of follow-up.

The higher mortality rates in the afternoon/night group during follow-up presented in our study was not previously described. While a recent study by du Fay de Lavallaz et al [[16]] found a higher acute myocardial infarction (AMI) incidence in the afternoon group and no difference in mortality according to the time of surgery, our study observed an almost 18% higher mortality rate in those operated in the afternoon / night without any difference in MACE incidence. We did not evaluate the incidence of MACE at long term follow-up, thus we could have missed some events. Also, since we had a higher-risk population with patients undergoing vascular surgeries that need cardiac referral, the elevated all-cause mortality rates observed may have overshadow other cardiac events. These results differs from the findings of a recent pilot study involving daytime variation on cardiac surgeries (on-pump aortic valve replacement), which demonstrated higher postoperative morbidity in patients operated in the morning [[15]].

The disparities between the studies might be explained because of different patient populations, human factors, and structural procedures. Compared with the other two cohorts, our patients had more comorbidity such as diabetes, hypertension, coronary artery disease, chronic heart failure and cerebrovascular arterial disease. Regarding the type of the surgery, our study focused on a specific type of higher risk surgery: arterial vascular surgeries. Also, urgent/emergency procedures were more prevalent than in the other studies. We decided to include urgent/emergency surgeries in our cohort because they represent a significant share of all vascular surgeries performed in our service. Therefore, we aimed to evaluate the same endpoints of elective surgeries to have a perception of how they would perform. Although the proportion of urgent/emergency surgeries could weight in the Cox Regression, we considered that our Regression Model and population was strong enough to estimate the effect size of each variable/confounder. At last, our study population is based on a tertiary health care center to which patients are usually referred when they have a more severe vascular condition or important cardiac or noncardiac comorbidities, often arriving at a poor clinical condition. Those combined situations could explain the high all-cause mortality rate overcoming the impact of MACE in the perioperative period.

Despite our standardized perioperative care management, it is possible that other non-measured factors might have influenced the outcomes, such as staffing, care units and other human factors. Not only patients' characteristics and clinical aspects are responsible for time distribution; operating issues and surgeries delay could affect the schedule of the surgeries, which were not assessed in our study. A study by van Zaane et al could not identify association between in-hospital mortality and the time of the day in urgent non-cardiac surgeries [[23]], but still we have to consider that the fatigue level of the surgeons and staff was not measured in our cohort, and this could be an important factor to explain our worse afternoon prognosis, since the "afternoon/night" period included hours from 12:01 p.m. and 6:59 a.m. Moreover, care units may have fewer employees working on afternoon/night shifts and, also, those working on late shifts could be less experienced. In fact, several studies have already demonstrated worse surgery outcomes in patients operated in weekends or holidays [[24]]. Finally, for elective surgeries, our hospital have the protocol of 8 hours of fasting before the procedure. However, due to delays and other non-measured factors patients might have been exposed to longer periods of fasting, especially for afternoon/night procedures. Prolonged fasting might have contributed to the observed outcomes [[26]]. The fasting period of urgent/emergency surgeries was not measured.

Our finding of daytime variation on PMI incidence is also different from the reported on previous cohorts in non-cardiac surgery [[16], [28]], which found no difference in the incidence of PMI when comparing morning vs afternoon. These studies on cardiovascular function, biorhythms and cardiac disorders still have many uncertainties in their conclusions. One plausible explanation is that the pathophysiological mechanisms involved in PMI are different depending on the type of procedure. Further studies are necessary to better understand the mechanisms related to perioperative myocardial injury.

Other secondary finding of our study was the association between preoperative use of statins and better prognosis of MACE at hospital discharge. Our cohort corroborate data from previous studies in which statins demonstrated to be effective in the prevention of cardiovascular events after vascular surgeries [[29]]. Additionally, anemia was usually associated with worse outcomes in terms of mortality and MACE, another well-known marker of frailty and worse perioperative outcomes [[30]].

Our study has some limitations. First, our study population involves patients from a tertiary health care center to which patients are usually referred when they have a more severe vascular condition or important cardiac or noncardiac comorbidities. We included in the cohort patients for whom cardiac consultation was requested, and although it is a common practice at our institution for vascular surgeons to request cardiac evaluation for all patients, we may have missed patients in the lower risk strata. In clinical practice, low risk patients according to anesthesiology evaluation are often directly sent to surgical theater without further consultation. Given the nature of the present study (retrospective analysis of prospective collected data) we don't have the number of patients operated without cardiac consultation, but we estimate a small number of cases that could not influence the final results of the present study. Second, despite having used a regression model to adjust for confounders, we must consider that other unmeasured confounders may have interacted with the results. Third, our study was made based on a specific type of surgery: arterial vascular surgeries. Although this enhances the power of the study and avoid possible confounders, such as different perioperative risks, our findings cannot be extrapolated for other types of surgery. Fourth, although we have considered urgent/emergency surgeries in our analysis, we have not measured the level of stress or tiredness and the level of experience of the healthcare professionals who performed the surgeries, which may add some degree of bias in our study.

The association between mortality rates, PMI, MACE and the period of the day in which surgeries are performed seem to be a promising field of study. The results of this cohort may lead to readjustments of simple medical procedures (such as determining the best time for the surgical procedure, which may indicate better prognosis) or in monitoring the patient (for example, determining how the multidisciplinary follow-up of a high-risk cardiovascular patient undergoing vascular surgery should be), simple measures that may have an impact on improving clinical practice. The cardioprotective strategy based only on the time of surgery indicates an economical and easy to implement measure for the prevention of postoperative cardiovascular complications.

Conclusion

In high-risk patients submitted to arterial vascular surgeries, being operated in the afternoon/night period was independently associated with increased all-cause mortality rates and higher incidence of PMI. We could not identify any influence of the period of the day in which surgeries are performed on the incidence of MACE.

Supporting information

S1 Fig. Distribution by surgery type from morning and afternoon/night groups.

AAAE = Abdominal Aortic Aneurysm Endovascular; AAAO/H = Open or Hybrid Abdominal Aortic Aneurysm; TAAEO/H = Thoracic Aortic Aneurysm Endovascular, Open or Hybrid; LLRO/E = Open or Endovascular Lower Limb Revascularization; EC = Endovascular Carotid; OC = Open Carotid; AMPUT = Amputations; OTHERS = Open or Endovascular Visceral Arteries and Other Procedures.

(TIF)

S2 Fig. Study population.

(TIF)

S3 Fig. Mortality in urgent/emergency surgeries.

(TIF)

S1 Table. STROBE statement—Checklist of items that should be included in reports of cohort studies.

(DOCX)

Footnotes 1 We have read the journal's policy and the authors of this manuscript have the following competing interests: Thiago Artioli received grant from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) [grant number 2019/17036-4]. Dr. Gualandro received grant from FAPESP and consulting fees from Roche, outside the submitted work. Dr. Francisco Akira Malta Cardozo received honoraria for lectures from Bayer. Dr. Calderaro received payment for lectures from Bayer, Daiichi Sankyo and Janssen; support for attending international meetings: Bayer and Daiichi Sankyo; participation on data safety monitoring board: Bayer. Dr. Ivan Benaduce Casella received consulting fees and honoraria for lectures from Bayer, Daiichi Sankyo and Boehringer Ingelheim. Dr. Bruno Caramelli received an unrestricted grant from the National Council for Scientific and Technological Development – CNPQ [grant number 304352/2016-0]. This does not alter our adherence to PLOS ONE policies on sharing data and materials. References Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Ann Surg1984; 199:223–33. doi: 10.1097/00000658-198402000-00016, 6696538 2 Herrington W, Lacey B, Sherliker P, et al. Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease. Circ Res. 2016 Feb 19; 118(4):535–46. doi: 10.1161/CIRCRESAHA.115.307611, 26892956 3 Landesberg G, Beattie WS, Mosseri M, et al. Perioperative myocardial infarction. Circulation2009; 119: 2936–44. doi: 10.1161/CIRCULATIONAHA.108.828228, 19506125 4 Mackey WC, Fleisher LA, Haider S, et al. Perioperative myocardial ischemic injury in high-risk vascular surgery patients: incidence and clinical significance in a prospective clinical trial. J Vasc Surg2006; 43:533–8. doi: 10.1016/j.jvs.2005.11.013, 16520168 5 Writing Committee for the VISION Study Investigators. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA2017; 317:1642. doi: 10.1001/jama.2017.4360, 28444280 6 Puelacher C, Lurati Buse G, Seeberger D, et al, BASEL-PMI Investigators. Perioperative Myocardial Injury After Noncardiac Surgery: Incidence, Mortality, and Characterization. Circulation. 201820; 137(12):1221–32. doi: 10.1161/CIRCULATIONAHA.117.030114, 29203498 7 George R, Menon VP, Edathadathil F, et al. Myocardial injury after noncardiac surgery-incidence and predictors from a prospective observational cohort study at an Indian tertiary care centre. Medicine (Baltimore). 2018 May; 97(19):e0402. doi: 10.1097/MD.0000000000010402, 29742684 8 Gualandro DM, Puelacher C, Mueller C. High-sensitivity cardiac troponin in acute conditions. Curr Opin Crit Care. 2014 Oct; 20(5):472–7. doi: 10.1097/MCC.0000000000000132, 25159476 9 Smolensky MH, Portaluppi F, Manfredini R, et al. Diurnal and twenty-four hour patterning of human diseases: cardiac, vascular, and respiratory diseases, conditions, and syndromes. Sleep Med Rev2015; 21:3–11. doi: 10.1016/j.smrv.2014.07.001, 25129838 Portaluppi F, Tiseo R, Smolensky MH, et al. Circadian rhythms and cardiovascular health. Sleep Med Rev2012; 16:151–66. doi: 10.1016/j.smrv.2011.04.003, 21641838 Suárez-Barrientos A, López-Romero P, Vivas D, et al. Circadian variations of infarct size in acute myocardial infarction. Heart2011; 97: 970–76. doi: 10.1136/hrt.2010.212621, 21525526 Reiter R, Swingen C, Moore L, Henry TD, Traverse JH. Circadian dependence of infarct size and left ventricular function after ST elevation myocardial infarction. Circ Res2012; 110: 105–10. doi: 10.1161/CIRCRESAHA.111.254284, 22095727 Sager HB, Husser O, Steffens S, et al. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction. Journal of Translational Medicine. 2019; 17:180. doi: 10.1186/s12967-019-1934-z, 31142323 Guo YF, Stein PK. Circadian rhythm in the cardiovascular system: chronocardiology. American Heart Journal. 2003 May; 145(5):779–86. doi: 10.1016/S0002-8703(02)94797-6, 12766733 Montaigne D, Marechal X, Modine T, et al. Daytime variation of perioperative myocardial injury in cardiac surgery and its prevention by rev-erbα antagonism: a single-centre propensity-matched cohort study and a randomised study. Lancet2017; 6736:1–11. du Fay de Lavallaz J, Puelacher C, Lurati Buse G, Bolliger D, Germanier D, Hidvegi R, et al. Daytime variation of perioperative myocardial injury in non- cardiac surgery and effect on outcome. Heart. 2019 Jun; 105(11):826–33. doi: 10.1136/heartjnl-2018-313876, 30541757 Dubois L, Vogt K, Vinden C, et al. Association between day of the week of elective surgery and postoperative mortality. CMAJ February 27, 2017189 (8) 303–309. doi: 10.1503/cmaj.160511, 27754897 Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction (2018). Eur Heart J. 2019 Jan 14; 40(3):237–69. doi: 10.1093/eurheartj/ehy462, 30165617 Gualandro DM, Yu PC, Caramelli B, et al. Fornari LS. III Guideline for perioperative evaluation of the Brazilian Society of Cardiology. Arq Bras Cardiol2017; 109(3Supl.1):1–104. Rohde LE, Montera MW, Bocchi EA, et al. Guideline for Chronic and Acute Heart Failure of the Brazilian Society of Cardiology. Arq Bras Cardiol. 2018; 111(3):436–539. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18(8):891–975. doi: 10.1002/ejhf.592, 27207191 Hicks KA, Tcheng JE, Bozkurt B, et al. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015; 132(4):302–61. doi: 10.1161/CIR.0000000000000156, 25547519 van Zaane B, van Klei WA, Buhre WF, et al. Nonelective surgery at night and in-hospital mortality: Prospective observational data from the European Surgical Outcomes Study. Eur J Anaesthesiol. 2015 Jul; 32(7):477–85. doi: 10.1097/EJA.0000000000000256, 26001104 Glance LG, Osler T, Li Y, Lustik SJ, et al. Outcomes are Worse in US Patients Undergoing Surgery on Weekends Compared with Weekdays. Med Care. 2016 Jun; 54(6):608–15. doi: 10.1097/MLR.0000000000000532, 27111750 Bendavid E, Kaganova Y, Needleman J, et al. Complication rates on weekends and weekdays in US hospitals. Am J Med. 2007 May; 120(5):422–8. doi: 10.1016/j.amjmed.2006.05.067, 17466653 Van Laake LW, Lüscher TF, Young ME. The circadian clock in cardiovascular regulation and disease: Lessons from the Nobel Prize in Physiology or Medicine 2017. Eur Heart J. 201821; 39(24):2326–9. doi: 10.1093/eurheartj/ehx775, 29309706 Brainard J, Gobel M, Bartels K, et al. Circadian rhythms in anesthesia and critical care medicine: potential importance of circadian disruptions. Semin Cardiothorac Vasc Anesth. 2015 Mar; 19(1):49–60. doi: 10.1177/1089253214553066, 25294583 Fournier S, Puricel S, Morawiec B, et al. Relationship between time of day and periprocedural myocardial infarction after elective angioplasty. Chronobiol Int. 2014 Mar; 31(2):206–13. doi: 10.3109/07420528.2013.839561, 24152063 Durazzo AES, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery. 2004 May; 39(5):967–75. doi: 10.1016/j.jvs.2004.01.004, 15111846 Ruan Y, Guo Y, Kowal P, et al. Association between anemia and frailty in 13,175 community-dwelling adults aged 50 years and older in China. BMC Geriatr. 2019 Dec 4; 19(1):327.

By Thiago Artioli; Danielle Menosi Gualandro; Francisco Akira Malta Cardozo; María Carmen Escalante Rojas; Daniela Calderaro; Pai Ching Yu; Ivan Benaduce Casella; Nelson de Luccia and Bruno Caramelli

Reported by Author; Author; Author; Author; Author; Author; Author; Author; Author

Titel:
Impact of the period of the day on all-cause mortality and major cardiovascular complications after arterial vascular surgeries.
Autor/in / Beteiligte Person: Artioli, T ; Gualandro, DM ; Cardozo, FAM ; Rojas, MCE ; Calderaro, D ; Yu, PC ; Casella, IB ; Luccia, N ; Caramelli, B
Link:
Zeitschrift: PloS one, Jg. 18 (2023-01-05), Heft 1, S. e0279873
Veröffentlichung: San Francisco, CA : Public Library of Science, 2023
Medientyp: academicJournal
ISSN: 1932-6203 (electronic)
DOI: 10.1371/journal.pone.0279873
Schlagwort:
  • Humans
  • Cohort Studies
  • Postoperative Complications epidemiology
  • Postoperative Complications etiology
  • Vascular Surgical Procedures adverse effects
  • Risk Factors
  • Heart Diseases
  • Myocardial Infarction etiology
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: English
  • Publication Type: Journal Article; Research Support, Non-U.S. Gov't
  • Language: English
  • [PLoS One] 2023 Jan 05; Vol. 18 (1), pp. e0279873. <i>Date of Electronic Publication: </i>2023 Jan 05 (<i>Print Publication: </i>2023).
  • MeSH Terms: Heart Diseases* ; Myocardial Infarction* / etiology ; Humans ; Cohort Studies ; Postoperative Complications / epidemiology ; Postoperative Complications / etiology ; Vascular Surgical Procedures / adverse effects ; Risk Factors
  • References: Circulation. 2009 Jun 9;119(22):2936-44. (PMID: 19506125) ; Sleep Med Rev. 2015 Jun;21:3-11. (PMID: 25129838) ; Med Care. 2016 Jun;54(6):608-15. (PMID: 27111750) ; J Vasc Surg. 2004 May;39(5):967-75; discussion 975-6. (PMID: 15111846) ; Curr Opin Crit Care. 2014 Oct;20(5):472-7. (PMID: 25159476) ; Am J Med. 2007 May;120(5):422-8. (PMID: 17466653) ; Eur J Anaesthesiol. 2015 Jul;32(7):477-85. (PMID: 26001104) ; J Transl Med. 2019 May 29;17(1):180. (PMID: 31142323) ; BMC Geriatr. 2019 Dec 4;19(1):327. (PMID: 31796000) ; Circulation. 2018 Mar 20;137(12):1221-1232. (PMID: 29203498) ; Arq Bras Cardiol. 2018 Sep;111(3):436-539. (PMID: 30379264) ; Lancet. 2018 Jan 6;391(10115):59-69. (PMID: 29107324) ; Eur Heart J. 2019 Jan 14;40(3):237-269. (PMID: 30165617) ; Am Heart J. 2003 May;145(5):779-86. (PMID: 12766733) ; Circ Res. 2012 Jan 6;110(1):105-10. (PMID: 22095727) ; J Vasc Surg. 2006 Mar;43(3):533-8. (PMID: 16520168) ; Semin Cardiothorac Vasc Anesth. 2015 Mar;19(1):49-60. (PMID: 25294583) ; Eur J Heart Fail. 2016 Aug;18(8):891-975. (PMID: 27207191) ; Arq Bras Cardiol. 2017 Jan-Feb;109(3 Supl 1):1-104. (PMID: 29044300) ; Circ Res. 2016 Feb 19;118(4):535-46. (PMID: 26892956) ; Ann Surg. 1984 Feb;199(2):223-33. (PMID: 6696538) ; Eur Heart J. 2018 Jun 21;39(24):2326-2329. (PMID: 29309706) ; CMAJ. 2017 Feb 27;189(8):E303-E309. (PMID: 27754897) ; Heart. 2011 Jun;97(12):970-6. (PMID: 21525526) ; Medicine (Baltimore). 2018 May;97(19):e0402. (PMID: 29742684) ; Sleep Med Rev. 2012 Apr;16(2):151-66. (PMID: 21641838) ; Heart. 2019 Jun;105(11):826-833. (PMID: 30541757) ; Chronobiol Int. 2014 Mar;31(2):206-13. (PMID: 24152063) ; JAMA. 2017 Apr 25;317(16):1642-1651. (PMID: 28444280) ; Circulation. 2015 Jul 28;132(4):302-61. (PMID: 25547519)
  • Entry Date(s): Date Created: 20230105 Date Completed: 20230109 Latest Revision: 20230319
  • Update Code: 20231215
  • PubMed Central ID: PMC9815593

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -